Assay News and Research

RSS

A novel assay for the rapid detection of SARS-CoV-2 variants

A new study discusses a new assay method designed by researchers to identify SARS-CoV-2 variants.

20 Jan 2022

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

Researchers investigate the cross-reactivity of the SARS-CoV-2 with pre-pandemic malaria-exposed sera samples collected from Cambodia.

19 Jan 2022

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

A new study discusses the targeted discovery of NTD-reactive antibodies from an individual who had recovered from SARS-CoV-2 infection.

19 Jan 2022

Emerging nanomaterials-based biosensor for detecting SARS-CoV-2

A new study aimed to highlight the different smart and emerging nanomaterials used to detect SARS-CoV-2.

19 Jan 2022

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Researchers have discovered a new way to induce immunity against the RBD.

19 Jan 2022

Improved SARS-CoV-2 surveillance testing with self-collected saliva

The findings from a recent study conducted in the United States suggest that combining saliva with a practical pooling protocol may open the door for easier surveillance testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), particularly in resource-limited settings.

18 Jan 2022

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic research collaboration to jointly discover and develop precision oncology drugs that target synthetic lethal engines key to tumor genome evolution.

18 Jan 2022

New genomic signature can spot aggressive tumor cells from primary, untreated prostate cancers

Many cases of early prostate cancer are dominated by cells that are slow-growing, often leading to a clinical decision to monitor for progression before initiating treatments that can have adverse side effects.

18 Jan 2022

Analyzing disease severity of SARS-CoV-2 Omicron variant using RNA dependent RNA polymerase target delay

In a new study, a team of researchers compared the severity of the SARS-CoV-2 Omicron variant to the Delta variant using the PCR proxy marker of RNA dependent RNA polymerase target delay.

18 Jan 2022

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

In this study, the researchers not only elucidate the recent bioconjugated nanomaterials for targeted diagnosis of SARS-CoV-2, but they also provide the rationale behind these developments by discussing the mechanisms and approaches.

18 Jan 2022

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

In a new study, researchers analyzed the neutralization of SARS-CoV-2 Omicron and D614G variants before and after subjects received COVID-19 booster vaccinations.

18 Jan 2022

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

In a new study, a team of researchers demonstrated that Japan had witnessed a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant-induced endemic between August and December 2021.

17 Jan 2022

SARS-CoV-2 Omicron has similar infectious viral load to Delta

Researchers compare SARS-CoV-2 pre-variants of concern strains to the Delta and Omicron VOCs.

16 Jan 2022

Omicron variant spike protein shows significantly weaker membrane fusion activity than other variants

New research suggests that the SARS-CoV-2 Omicron spike protein requires significantly higher levels of ACE2 for efficient membrane fusion, lagging behind other variants.

14 Jan 2022

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Researchers conducted a detailed epitope mapping of Np and developed an experimental double antigen-based ELISA.

13 Jan 2022

Assessing how autoantibodies in COVID-19 correlate with anti-viral humoral responses

Researchers screen several systemic autoantibodies to assess their association with the severity of COVID-19.

13 Jan 2022

Study confirms waning immunity in adolescents following two doses of mRNA COVID-19 vaccines

Researchers test the durability of antibodies produced by a vaccine-induced full-length SARS-CoV-2 spike protein and receptor-binding domain.

13 Jan 2022

FAU receives $1.3 million NIH grant for automated HIV self-testing assay

As of 2020, there were 37.7 million people globally living with HIV and 680,000 people died from AIDS-related illnesses last year. Since the start of the epidemic, more than 36.3 million people have died from AIDS-related illnesses.

13 Jan 2022

Exploring the structural basis of antibody evasion and enhanced transmission of the SARS-CoV-2 Omicron variant

In a new study, researchers used cryogenic electron microscopy (cryo-EM) analysis to capture the open and closed states of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant’s spike protein.

13 Jan 2022

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

In a new study, researchers assessed the sera from COVID-19 infected and vaccinated individuals against the receptor-binding domain in the spike protein of the SARS-CoV-2 wildtype virus and its variants.

13 Jan 2022

Assay News and Research

A novel assay for the rapid detection of SARS-CoV-2 variants

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

Emerging nanomaterials-based biosensor for detecting SARS-CoV-2

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Improved SARS-CoV-2 surveillance testing with self-collected saliva

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

New genomic signature can spot aggressive tumor cells from primary, untreated prostate cancers

Analyzing disease severity of SARS-CoV-2 Omicron variant using RNA dependent RNA polymerase target delay

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

SARS-CoV-2 Omicron has similar infectious viral load to Delta

Omicron variant spike protein shows significantly weaker membrane fusion activity than other variants

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Assessing how autoantibodies in COVID-19 correlate with anti-viral humoral responses

Study confirms waning immunity in adolescents following two doses of mRNA COVID-19 vaccines

FAU receives $1.3 million NIH grant for automated HIV self-testing assay

Exploring the structural basis of antibody evasion and enhanced transmission of the SARS-CoV-2 Omicron variant

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

eBook: Using iPSCs models for human disease research and drug discovery eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News